Disposable Syringes Market Size to Reach USD 14.49 Bn by 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Disposable Syringes Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Disposable Syringes Market

5.1. Covid-19: Disposable Syringes Industry Impact
5.2. Disposable Syringes Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Disposable Syringes Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Disposable Syringes Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Disposable Syringes Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing patient awareness
6.1.1.2. Increased health care expenditure
6.1.2. Market Restraints
6.1.2.1. High cost
6.1.3. Market Opportunities
6.1.3.1. Large pool of geriatric population

Chapter 7. Global Disposable Syringes Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Disposable Syringes Market Revenue by Market Players
7.1.1.2. Disposable Syringes Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Disposable Syringes Market, By Type

8.1. Disposable Syringes Market, by Type
8.1.1. Conventional Syringes
8.1.1.1. Market Revenue and Forecast
8.1.2. Safety Syringes
8.1.2.1. Market Revenue and Forecast
8.1.3. Retractable Safety Syringes
8.1.3.1. Market Revenue and Forecast
8.1.4. Non-Retractable Safety Syringes
8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Disposable Syringes Market, By Application

9.1. Disposable Syringes Market, by Application
9.1.1. Immunization Injections
9.1.1.1. Market Revenue and Forecast
9.1.2. Therapeutic Injections
9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Disposable Syringes Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Type
10.1.2. Market Revenue Forecast by Application
10.1.3. U.S
10.1.3.1. Market Revenue Forecast
10.1.4. Canada
10.1.4.1. Market Revenue Forecast
10.2. Europe
10.2.1. Market Revenue Forecast by Type
10.2.2. Market Revenue Forecast by Application
10.2.3. UK
10.2.3.1. Market Revenue Forecast
10.2.4. Germany
10.2.4.1. Market Revenue Forecast
10.2.5. France
10.2.5.1. Market Revenue Forecast
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Type
10.3.2. Market Revenue Forecast by Application
10.3.3. China
10.3.3.1. Market Revenue Forecast
10.3.4. India
10.3.4.1. Market Revenue Forecast
10.3.5. Japan
10.3.5.1. Market Revenue Forecast
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast
10.4. LATAM
10.4.1. Market Revenue Forecast by Type
10.4.2. Market Revenue Forecast by Application
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Type
10.5.2. Market Revenue Forecast by Application
10.5.3. GCC
10.5.3.1. Market Revenue Forecast
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast

Chapter 11. Company Profiles

11.1. Fresenius Kabi AG
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Type Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. Becton, Dickinson and Company
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Type Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. Flextronics International
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Type Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. Covidien
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Type Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. Braun Medical, Inc.
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Type Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Novo Nordisk
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Type Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. Vita Needle Company
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Type Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. Baxter International, Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Type Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. Retractable Technologies, Inc.
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Type Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
11.10. Henke-Sass, Wolf
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Type Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin
11.10.4. Recent Developments and Strategies
11.11. UltiMed, Inc.
11.11.1. Company Overview, Business Information, Regional Presence
11.11.2. Product Portfolio Analysis
11.11.2.1. Type Details, Specification, Application
11.11.3. Revenue, Price, and Gross Margin
11.11.4. Recent Developments and Strategies
11.12. Terumo Corporation
11.12.1. Company Overview, Business Information, Regional Presence
11.12.2. Product Portfolio Analysis
11.12.2.1. Type Details, Specification, Application
11.12.3. Revenue, Price, and Gross Margin
11.12.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The disposable syringes market size was reached at USD 7.91 billion in 2024 and is predicted to surpass around USD 14.49 billion by 2034.

The global disposable syringes market is growing at a noteworthy CAGR of 6.3% over forecast period 2025 to 2034.

On the basis of type safety syringe division was dominant with significant share in 2024. The growth of the safety syringe is owing to benefits that safety bulbs offer outruns their duration of existence even at low cost over disposables, which further shifts the preference toward safety syringes.

In 2024, the North America dictated the global industry with a market stake of greater than 41%.

The key companies functioning in the worldwide disposable syringes market are Fresenius Kabi, Covidien, Becton, Dickinson and Company, Flextronics International, Braun Medical, Inc., Novo Nordisk, Vita Needle Company, Baxter International, Inc., Retractable Technologies, Inc., UltiMed, Inc., Henke-Sass, Wolf, and Terumo Corporation among others.

Asia Pacific disposable syringes market is anticipated to grow at significant CAGR over the forecast period 2025 to 2034.

Factors such as increasing number of patients at risk of developing stroke, increasing patient awareness, increased health care expenditure, large pool of geriatric population, growing usage of injectable drugs, higher bioavailability of injectable drugs, growing instances of needlestick injuries, increasing cases of chronic disorders such as diabetes and chronic, and increased preference of intravenous route of drug administration are driving the growth of disposable syringes market.